Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Flea treatment recalled over labelling error
The VMD has issued a product defect recall alert for a single batch of Johnson's 4Fleas 80mg Spot-on solution for Cats.
Recall concerns single batch of Johnson’s 4Fleas 80mg Spot-on Solution for Cats.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Johnson’s 4Fleas 80mg Spot-on Solution for Cats, manufactured by Johnson’s Veterinary Products Ltd.

In a press release, the VMD reports that the treatment was being recalled owing to a labelling error.

On the leaflet provided in the box, it states: 'For the prevention and treatment and prevention of flea (Ctenocephalides felis) infestations on cats of less than 4 kg bodyweight.'

However, the leaflet should state: 'For the prevention and treatment and prevention of flea (Ctenocephalides felis) infestations on cats greater or equal to 4 kg bodyweight.'

The recall affects only a single batch – DO41 Johnson's 4Fleas Large Cat 6X2X0.8ml – KP0F3U7

The VMD writes: 'Johnson’s Veterinary Products Ltd is contacting wholesale dealers to examine inventory immediately and quarantine products subject to this recall. This issue only applies to the batch listed above. Any other batches of Johnson’s 4Fleas 80mg Spot-on Solution for Cats are not impacted and may continue to be distributed.'

For further details about the recall contact Grant Exall, quality assurance/WQP, email: Grantexall@johnsons-vet.com, or Nick Franks, sales director, email Nickfranks@johnsons-vet.com, or Tel: 0121 378 1684.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.